Latest News about FDA
Recent news which mentions FDA
Why Is Inflammatory Disease/Oncology-Focused RAPT Therapeutics Shares Tumbling Today?
February 20, 2024
From Benzinga
Why AstraZeneca Stock Is Trading Higher Tuesday
February 20, 2024
From Benzinga
Politics Over Public Health? FDA Head Expresses Concern Over Biden's Delay Of Menthol Cigarette Ban
February 17, 2024
Tickers
NEWS
From Benzinga
Cybin Inc. Q3 Earnings: Clinical Advances Amid Financial Loss
February 16, 2024
From Benzinga
FDA Fast-Tracks Review Of Sarepta's Groundbreaking Muscular Dystrophy Treatment With $1B Market In Sight
February 16, 2024
From Benzinga
Why Is Gilead Sciences Stock Trading Lower Today?
February 16, 2024
From Benzinga
Marjorie Taylor Greene Faces Democratic Criticism Over 'Vulgarity' And 'Conspiracy' In Vaccine Hearing
February 16, 2024
Tickers
NEWS
From Benzinga
Cardiology's Quantum Leap: FDA's Advisory Panel Gives Thumbs Up To Abbott's Minimally Invasive Heart Valve Repair Device
February 14, 2024
From Benzinga
Substance Use Disorder Company Narrows Q2 Net Loss, Reports Progress On Cannabinoid Intoxication Drug
February 14, 2024
From Benzinga
US Police Seizures Of Psychedelic Mushrooms Increased In Recent Years, New Study Finds
February 12, 2024
From Benzinga
From Benzinga
Why Is Inherited Rare Disease Focused-Larimar Therapeutics Stock Trading Lower Today?
February 12, 2024
From Benzinga
FDA Advisors Set To Discuss Abbott's TriClip For Heart Valve Disorder As Questions On Pivotal Trial Loom
February 12, 2024
From Benzinga
From Benzinga
Catalent's Bloomington Plant Making Novo Nordisk's Obesity Drug Faces FDA Scrutiny Regarding Drug Manufacturing Concerns
February 07, 2024
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.